EASL | The Home of Hepatology’s Post

Happening now! People diagnosed with early ER-positive breast cancer are likely to be cured of their breast cancer, but some will still experience a recurrence. In this episode of Breast Cancer Breakthroughs, hear from experts Dr. Sara Tolaney and Dr. Aditya Bardia about how researchers are working to find ways to lower risk for recurrence and how new research on early ER-positive breast cancer can save lives. Watch here: https://bit.ly/3X1yPW0

On this #NationalClinicalTrialsDay, we are highlighting a troubling finding published by the Lancet Breast Cancer Commission which shows that participation in breast cancer clinical trials is low and does not reflect the diversity of the breast cancer community. To find the cures for breast cancer, all communities must be represented in breast cancer research. This is why Susan G. Komen launched ShareForCures, a revolutionary breast cancer research registry that connects scientists with information from people who have or have had breast cancer. To join this inclusive registry, or learn more https://lnkd.in/eN2zahSS

October is Breast Cancer Awareness Month. 🎗️ The month aims to promote understanding and prevention of the disease, which affects 2.3 million women worldwide.¹ Throughout this month, we'll be highlighting impactful research and developments that address common challenges and support drug discovery programs. Did you know, one essential tool in cancer research are tissue microarrays (TMAs), allowing for the simultaneous high-throughput analysis of numerous breast cancer samples. Utilizing these arrays, researchers can achieve deeper insights into the histopathological and molecular features of breast cancer, significantly advancing our understanding and treatment of this complex disease. Discover more ➡️ https://hubs.la/Q02RJYB30 #BreastCancer #BreastCancerAwarenessMonth ¹https://hubs.la/Q02RJPqx0

Today is Global #LobularBreastCancer Awareness Day. The ACS NBCRT is proud to partner with Lobular Breast Cancer Alliance Inc. in raising awareness and advancing research for this unique form of breast cancer. LBCA has curated a valuable compilation of resources for clinicians and researchers, including a must-watch video featuring LBCA Executive Director Laurie Hutcheson. In the video, Laurie discusses why clinical trial participation is essential to discovering new breast cancer treatments and improving outcomes. Watch here: https://lnkd.in/gPP_Rhhv #lobularbreastcancer #BreastCancerAwareness #BreastCancer

Metastatic Breast Cancer Awareness Day is 13th October. 🎗️ We're continuing to highlight impactful research and developments as part of Breast Cancer Awareness Month. Metastatic disease continues to be the leading cause of breast cancer-related deaths. In this blog post, we explore how to leverage Patient-Derived Xenograft (PDX) models for modeling metastatic breast cancer. We will look at models that spontaneously recapitulate the clinical metastatic process; a feature that is missing from conventional xenograft models. Read the blog post ➡️ https://hubs.la/Q02SX5Kk0

Today is #Immune2Cancer Day, and we are excited to support our partners at the Cancer Research Institute (CRI) in spreading awareness about the importance of cancer immunotherapy research—including clinical trials using focused ultrasound. Focused ultrasound can initiate a powerful anti-tumor immune response that could potentially enhance the effectiveness of cancer immunotherapeutics, reduce side effects, and improve patient response. Learn more about how focused ultrasound can be a key component in achieving a future immune to cancer: https://ow.ly/cSVo50ShaAq

Clinical trials aren’t discussed frequently enough with patients. Our latest State of Patient Empowerment survey found that only 28% of breast cancer patients are presented with a clinical trial. But, there are exciting new trials underway in early breast cancer. ⏩to the 5-min mark of our latest Ask the Expert webinar series to learn more about some of the trials discussed at the San Antonio Breast Cancer Symposium. https://lnkd.in/eueTJ_ud #SABCS #breastcancer #breastcancertrials #earlystagebreastcancer

Very interesting webinar that will discuss a hot topic for 2024 which is FGFR3 alterations. 💊 In January and summer 2024 we saw US and EU drug approvals in this area and testing is a key factor to identify who could be eligible for such treatments. Register here below ⬇ #oncology #precisionmedicine #biomarkers #webinar

On this #NationalClinicalTrialsDay, we are highlighting a troubling finding published by the Lancet Breast Cancer Commission which shows that participation in breast cancer clinical trials is low and does not reflect the diversity of the breast cancer community. To find the cures for breast cancer, all communities must be represented in breast cancer research. This is why Komen launched ShareForCures, a revolutionary breast cancer research registry that connects scientists with information from people who have or have had breast cancer. To join this inclusive registry, or learn more https://bit.ly/3MMwqwd

On this #NationalClinicalTrialsDay, we are highlighting a troubling finding published by the Lancet Breast Cancer Commission which shows that participation in breast cancer clinical trials is low and does not reflect the diversity of the breast cancer community. To find the cures for breast cancer, all communities must be represented in breast cancer research. This is why Komen launched ShareForCures, a revolutionary breast cancer research registry that connects scientists with information from people who have or have had breast cancer. To join this inclusive registry, or learn more https://bit.ly/3MMwqwd